What is CONMED's treasury stock?

CONMED (CNMD) reported treasury stock of $49.04M in Q1 2026.

How has CONMED's treasury stock changed year-over-year?

CONMED's treasury stock increased by 238.0% year-over-year, from $14.51M to $49.04M.

What is the long-term trend for CONMED's treasury stock?

Over 5 years (2020 to 2025), CONMED's treasury stock has grown at a -28.2% compound annual growth rate (CAGR), from $67.64M to $12.89M.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

CONMED CNMD Treasury Stock

Treasury Stock at other companies

Johnson & JohnsonJNJ

$76.26B+0.5%

Zimmer Biomet HoldingsZBH

$9.14B+5.8%

IAR

Integra LifeSciencesIART

$687.12M-0.5%

LivaNovaLIVN

$1.17M-18.2%

LeMaitre VascularLMAT

$17.9M+10.4%

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.07B-35.6%

Enterprise value$1.89B-24.5%

P/E19.4×+5.5×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's treasury stock?: CONMED (CNMD) reported treasury stock of $49.04M in Q1 2026.
How has CONMED's treasury stock changed year-over-year?: CONMED's treasury stock increased by 238.0% year-over-year, from $14.51M to $49.04M.
What is the long-term trend for CONMED's treasury stock?: Over 5 years (2020 to 2025), CONMED's treasury stock has grown at a -28.2% compound annual growth rate (CAGR), from $67.64M to $12.89M.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.